GlaxoSmithKline

Moncef Slaoui, who led Trump's Operation Warp Speed, was dismissed as chair of Galvani Bioelectronics' board of directors after an investigation.
David Sinclair stirred up controversy before when he promoted — and got $8 million — off a “miraculous molecule.”
It's 23andMe's latest collaboration to develop new drugs with genetic data from customers who volunteered to participate.
Sales of Biktarvy are expected to be about $1 billion this year.
Gottlieb's financial ties to the healthcare industry are extensive.